Home
About
Overview
Sharing Data
ORCID
Help
History (51)
PHD Zinc Fingers
Claudin-2
Pre-B-Cell Leukemia Transcription Factor 1
Brooks, Joshua
Changing lanes: extending CAR T-cell therapy to high-risk plasma cell dyscrasias.
See All 51 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Changing lanes: extending CAR T-cell therapy to high-risk plasma cell dyscrasias.
Changing lanes: extending CAR T-cell therapy to high-risk plasma cell dyscrasias. Front Immunol. 2025; 16:1558275.
View in:
PubMed
subject areas
Humans
Immunoglobulin Light-chain Amyloidosis
Immunotherapy, Adoptive
Leukemia, Plasma Cell
Paraproteinemias
Treatment Outcome
authors with profiles
Benjamin Derman